dc.contributor.author | Dowsett, M | |
dc.contributor.author | Turner, N | |
dc.date.accessioned | 2019-03-05T16:34:22Z | |
dc.date.issued | 2019-03-20 | |
dc.identifier.citation | Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 37 (9), pp. 689 - 692 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/3136 | |
dc.identifier.eissn | 1527-7755 | |
dc.identifier.doi | 10.1200/jco.18.01412 | |
dc.format | Print-Electronic | |
dc.format.extent | 689 - 692 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | |
dc.rights.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
dc.subject | Humans | |
dc.subject | Breast Neoplasms | |
dc.subject | Neoplasm Metastasis | |
dc.subject | Neoplasm Recurrence, Local | |
dc.subject | Treatment Outcome | |
dc.subject | Risk Assessment | |
dc.subject | Risk Factors | |
dc.subject | Predictive Value of Tests | |
dc.subject | Gene Expression Profiling | |
dc.subject | Decision Support Techniques | |
dc.subject | Models, Genetic | |
dc.subject | Time Factors | |
dc.subject | Female | |
dc.subject | Transcriptome | |
dc.subject | Biomarkers, Tumor | |
dc.subject | Clinical Decision-Making | |
dc.title | Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic Risk. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2018-12-19 | |
rioxxterms.versionofrecord | 10.1200/jco.18.01412 | |
rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
rioxxterms.licenseref.startdate | 2019-03 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | |
pubs.issue | 9 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Endocrinology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Molecular Oncology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Endocrinology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Endocrinology/Endocrinology (hon.) | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Endocrinology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Molecular Oncology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Endocrinology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Endocrinology/Endocrinology (hon.) | |
pubs.publication-status | Published | |
pubs.volume | 37 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Molecular Oncology | |
icr.researchteam | Endocrinology | |
dc.contributor.icrauthor | Turner, Nicholas | |